Series B - New Haven Pharmaceuticals - Oct 23, 2014 Funding Round Profile - Cointime

Bitcoin $99,201.34 +1.04%
Ethereum $3,298.01 -1.63%
BNB $625.25 +0.47%
Optimism $2.12 +1.36%
Arbitrum $0.78 -1.55%
Solana $255.38 +0.30%
Polygon $0.48 +8.08%
Cosmos $7.35 +16.13%
Avalanche $40.41 +12.60%

Bitcoin $99,201.34 +1.04%
Ethereum $3,298.01 -1.63%
BNB $625.25 +0.47%
Optimism $2.12 +1.36%
Arbitrum $0.78 -1.55%
Solana $255.38 +0.30%
Polygon $0.48 +8.08%
Cosmos $7.35 +16.13%
Avalanche $40.41 +12.60%

New Haven Pharmaceuticals

company

Funding Round

Series B

Money Raised

$ 11.78M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
EJ Funds	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Dec 31, 2013	Debt Financing	0	Advantage Capital	Detail
Oct 29, 2012	Series A	$ 6.49M	Advantage Capital,EJ Funds	Detail
Sep 30, 2012	Series Unknown	0	Advantage Capital	Detail